维普中文期刊产品整合服务
51篇 您的检索式:作者名="Lakoski"
    题名 作者 年代 出处 被引量
1Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress显示文摘Cavanaugh JE Jaumotte JD Lakoski JM 2006J Neurosci Res2006,84,6:1
2The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA)显示文摘Lakoski SG Cushman M Patmas W 0,,:1
3C-reactive protein concentration and incident hypertension in young adults: the CARDIA study 显示文摘Lakoski SG Herrington DM Siscovick DM 2006Arch Intern Med2006,166,3:1
4Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study 显示文摘Lakoski SG Liu Y Brosnihan KB 2008Atherosclerosis2008,197,1:1
5Gender and C-reactive protein : Data from the Multiethnic Study of Atheroscleresis (MESA) cohort 显示文摘Lakoski S 2006Am heart J2006,152,3:1
6Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study 显示文摘Lakoski SG Liu Y Brosnihan KB 2008Atheroselerosis2008,197,1:1
7Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study显示文摘LAKOSKI S G LIU Y BROSNIHAN K B 2008Atherosclerosis2008,197,:1
8Genetic and metabolic determinants of plasma PCSK9 levels 显示文摘Lakoski SG Lagace TA Cohen JC 2009J Clin Endocrinol Metab2009,94,7:1
9The association between innate immunity gene (IRAK1) and C-reactive protein in the diabetes heart study显示文摘Lakoski SG Li L Langefeld CD 0,,03:1
10Genetic and Metabolic Determinants of Plasma PCSK9 Levels显示文摘Susan G. Lakoski Thomas A. Lagace Jonathan C. Cohen Jay D. Horton Helen H. Hobbs 2009The Journal of Clinical Endocrinology & Metabolism2009,,7:1
11Genetic and metabolic determinants of plasma PCSK9 levels显示文摘LAKOSKI S G LAGACE T A COHEN J C 2009J Clin Endocrinol Metab2009,94,:1
12C-reactive protein concentration and incident hypertension in young adults:the CARDIA study显示文摘Lakoski SG Herrington DM Siscovick DM 2006Arch Intern Med2006,166,3:1
13Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study显示文摘Lakoski SG Liu Y Brosnihan KB 2008Atherosclerosis2008,197,1:1
14The Association of Framingham and Reynolds Risk Scores With Incidence and Progression of Coronary Artery Calcification in MESA (Multi-Ethnic Study of Atherosclerosis)显示文摘Andrew P. DeFilippis Michael J. Blaha Chiadi E. Ndumele Matthew J. Budoff Donald M. Lloyd-Jones Robyn L. McClelland Susan G. Lakoski Mary Cushman Nathan D. Wong Roger S. Blumenthal Joao Lima Khurram Nasir 2011Journal of the American College of Cardiology2011,,20:1
15Advancing institutional efforts to support research mentorship:a conceptual framework and self-assessment tool显示文摘Keyser D J Lakoski JM Lara-Cinisomo S 0,,03:1
16Dynamic monitoring of carnitine and acetylcarnitine in the trimethylamine signal after exercise in human skeletal muscle by 7 T 1H-MRS显示文摘Ren J Lakoski S Hailer R G 2013Magn Reson Med2013,69,1:1
17The association between innate immunity gene( IRAK1 )and C-reactive protein in the diabetes heart study 显示文摘Lakoski SG Li L Langefeld CD 2007Exp Mol Pathol2007,82,3:1
18Interleukin-10 concen-tration and coronary heart disease (CHD) event risk in the estrogenreplacement and atherosclerosis (ERA )study显示文摘Lakoski SG Liu Y Brsnihan KB 2008Atherosclerosis2008,197,1:1
19Genetic and metabolic determinants of plasma PCSK9 levels显示文摘Lakoski SG Lagace TA Cohen JC 0,,:1
20The relationship between inflammation,obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis(MESA)显示文摘Lakoski SG Cushman M 2011Hum Hypertens2011,25,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费